{"id":"W2126270742","doi":"10.1016/j.lungcan.2009.11.018","title":"Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology","year":2009,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pemetrexed; Medicine; Erlotinib; Gefitinib; Oncology; Cetuximab; Bevacizumab; Internal medicine; Lung cancer; Adenocarcinoma; Clinical trial; Chemotherapy; Cancer; Epidermal growth factor receptor; Cisplatin; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002354864,0.0003342013,0.001801007,0.0002136443,0.00003311336,0.000004073315,0.0002308698,0.0002804339,0.00006389949],"category_scores_gemma":[0.00008977702,0.0002251076,0.0003548017,0.0004406138,0.00004615069,0.00007543611,0.00003612487,0.0001477777,2.084006e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004538605,"about_ca_system_score_gemma":0.001430386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005839963,"about_ca_topic_score_gemma":0.005909061,"domain_scores_codex":[0.9974024,0.0001627806,0.001388417,0.0003968044,0.0004143017,0.0002352633],"domain_scores_gemma":[0.9964308,0.000198984,0.002393207,0.00044991,0.0004643491,0.00006280268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004041657,0.00139197,0.00364138,0.005659519,0.001305977,0.00000650206,0.004334113,0.000767379,0.00008415378,0.000004239354,0.0003381485,0.9820625],"study_design_scores_gemma":[0.007236693,0.001551867,0.00298668,0.05208242,0.006808992,0.000004630886,0.0004453757,0.000503578,0.00473946,0.000008087071,0.9232584,0.0003738455],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01063804,0.9820114,0.000002224985,0.00112139,0.0007997632,0.002223581,0.001023439,0.00001046428,0.002169717],"genre_scores_gemma":[0.006168726,0.9900777,0.0004916213,0.00003426832,0.0002400808,0.000519323,0.0003745883,0.00003797593,0.002055721],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9816886,"threshold_uncertainty_score":0.9992828,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04081135753217011,"score_gpt":0.4496065279671237,"score_spread":0.4087951704349536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}